Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Solriamfetol
Other

Solriamfetol

Tracked across 1 events · 6 articles · First seen Jun 03, 2026 · Last active Jun 03, 2026

Sentiment
20
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 20
Business
Axsome resolves SUNOSI patent litigation
Impact: Solriamfetol is the product at the center of the patent litigation, and its continued market exclusivity is crucial for Axsome Therapeutics's revenue.
Jun 03, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Solriamfetol live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.